
    
      Mania can be regarded as an autoregulatory mechanism to enhance unstable vigilance. There is
      increasing evidence that psychostimulants that increase vigilance may be effective in
      treating mania. However, controlled studies are lacking.

      This is a two-arm, randomised, placebo-controlled, double-blind, parallel, multi-centre phase
      IIIb exploratory study to evaluate the efficacy and safety of methylphenidate in the initial
      treatment of acute mania in patients with bipolar affective disorders.
    
  